Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.37 |
| ▸ | MAPT | P10636 | 2/20 | 0.37 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.37 |
| ▸ | LMNA | P02545 | 2/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.37 |
| ▸ | GAA | P10253 | 2/20 | 0.35 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.33 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.33 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.33 |
| ▸ | GSK3B | P49841 | 1/20 | 0.32 |
| ▸ | TP53 | P04637 | 2/20 | 0.32 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.31 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.31 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2203029 | 0.84 | SLC6A2 (0.41) | CYP1A2MAPTLMNASLC6A2SLC6A4 | |
| SCHEMBL5983948 | 0.82 | SLC6A3 (0.37) | L3MBTL1MAPTNPSR1LMNATDP1 | |
| SCHEMBL7705153 | 0.70 | HTR1A (0.43) | TP53SLC6A2SLC6A4SLC6A3 | |
| SCHEMBL24342627 | 0.69 | L3MBTL1 (0.42) | CYP1A2CYP2C19L3MBTL1MAPTNPSR1 | |
| SCHEMBL12049774 | 0.69 | CYP1A2 (0.41) | CYP1A2CYP2C19L3MBTL1MAPTNPSR1 | |
| SCHEMBL20611963 | 0.68 | LSS (0.50) | CYP1A2CYP2C19SLC6A2SLC6A4SLC6A3 | |
| SCHEMBL2749914 | 0.67 | CYP1A2 (0.39) | CYP1A2CYP2C19L3MBTL1MAPTNPSR1 | |
| SCHEMBL5981666 | 0.67 | ALDH1A1 (0.35) | L3MBTL1MAPTLMNATDP1 | |
| SCHEMBL24394595 | 0.67 | GSK3B (0.45) | CYP1A2GSK3BSLC6A2SLC6A4SLC6A3 | |
| SCHEMBL24342636 | 0.67 | GSK3B (0.45) | GSK3B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1478645-A2 | QUINOLINONE DERIVATIVES FOR TREATING CELL PROLIFERATION RELATED DISORDERS | Amgen Inc. (US) | 2004-11-24 | — | — | EP | disclosed |
| WO-2003066630-A2 | QUINOLINONE DERIVATIVES FOR TREATING CELL PROLIFERATION RELATED DISORDERS | AMGEN INC. (US) | 2003-08-14 | — | — | WO | disclosed |
| EP-1309589-A2 | UREA COMPOUNDS AND METHODS OF USES | Amgen Inc. (US) | 2003-05-14 | — | — | EP | disclosed |
| WO-2002014311-A2 | UREA COMPOUNDS AND METHODS OF USES | AMGEN INC. (US) | 2002-02-21 | — | — | WO | disclosed |